Table 3.

Risk of hypertension, dyslipidemia, diabetes, central obesity, overweight and obesity in MAFLD and NAFLD patients.

	Male		Female
	MAFLD	NAFLD	MAFLD	NAFLD
	OR (95%CI)	OR (95%CI)	OR (95%CI)	OR (95%CI)
Hypertension	2.3 (2.03,2.61)	1.48 (1.3,1.67)	2.35 (2.11,2.62)	2.08 (1.87,2.32)
Dyslipidemia	3.65 (3.23,4.12)	2.31 (2.05,2.59)	2.59 (2.33,2.88)	2.43 (2.19,2.7)
Diabetes	2.82 (2.38,3.34)	1.87 (1.6,2.19)	2.93 (2.5,3.43)	2.63 (2.26,3.07)
Overweight & Obesity	11.58 (9.86,13.61)	4.15 (3.6,4.79)	9.47 (8.34,10.75)	6.63 (5.89,7.48)
Central obesity	6.63 (5.7,7.73)	2.71 (2.38,3.08)	6.53 (5.85,7.3)	5.25 (4.71,5.85)
	B (95% CI)	B (95% CI)	B (95% CI)	B (95% CI)
Systolic blood pressure	6.03 (4.93,7.14)	2.61 (1.49,3.72)	7.47 (6.54,8.41)	6.23 (5.3,7.17)
LDL cholesterol	0.31 (0.27,0.35)	0.12 (0.08,0.17)	0.26 (0.23,0.3)	0.24 (0.2,0.27)
Fasting glucose	0.5 (0.42,0.59)	0.37 (0.28,0.45)	0.41 (0.35,0.47)	0.37 (0.31,0.43)
glycosylated hemoglobin	0.36 (0.3,0.41)	0.19 (0.13,0.24)	0.36 (0.32,0.4)	0.32 (0.28,0.36)
Body mass index	3.44 (3.27,3.61)	2.28 (2.1,2.47)	3.52 (3.37,3.68)	3.18 (3.02,3.33)
Waist circumference	9.18 (8.7,9.66)	5.57 (5.05,6.1)	8.64 (8.25,9.03)	7.76 (7.37,8.16)

Data are expressed as OR/B (95% CI). All analyses were adjusted for age and current smoking.